Back to results
US 2021/0341467 A1Published application
Portable devices and methods for detecting and identifying compounds in saliva
AssigneePelican Diagnostics Inc.
InventorRaj Reddy
Life of this patent
Estimating the term…
Abstract
This disclosure relates to portable devices for SARS-COV-2 Antigen (SC2A), a biomarker for the detection of Coronavirus disease 2019 (COVID19). Diagnosis of viral infections such as SARS-COV-2 can be obtained in the early stages of a disease by detection of viral antigens (e.g., SC2A) directly in the clinical specimen.
Claims20
A portable device for detecting and identifying antigen compounds in the saliva or antibodies in the blood of a subject comprising:
- a. a biosensor connected to a device;
- b. a sensor module disposed in a housing of the device, wherein the sensor module collects data, and thereby detects and identifies one or more antigen compounds and/or one or more antibody compounds in a saliva or blood sample;
- c. a communication apparatus disposed to the sensor module, wherein the communication apparatus electrically transmits the collected data;
- and
- d. a battery disposed to the communication apparatus and the sensor module.
2 more elements
A sensor comprising:
- a. a gold coated interdigital electrode, wherein the interdigital electrode comprises a nanocomposite of graphene nanoplatelet with diblock-co-polymer, wherein the nanocomposite includes one or more immobilized antigen molecules;
- and
- b. a support on which the electrodes are disposed.
A method for detecting and identifying antigen compounds from a fluid sample of a subject comprising:
- a. collecting and chemically treating a fluid sample of a subject;
- b. collecting the sample in a connected device, wherein the device comprises a housing including at least a sensor module having at least one sensor, a communication apparatus, and a battery, wherein the at least one sensor comprises one or more electrodes and at least one antibody bound to the one or more electrodes via 3,3′-Dithiodipropionic acid (N-hydroxysuccinimide ester) (DTSP) —self-assembled-monolayer (SAM);
- c. collecting data about the presence and identity of one or more antigen compounds with the sensor module, wherein a first antigen compound binds to the at least one antibody bound to the one or more electrodes;
- d. communicating collected data via the communication apparatus to a processing apparatus;
- and
- e. processing the communicated data to detect and identify the one or more antigen compounds, wherein the first antigen compound is identified as SARS-COV-2 antigen (SC2A).
3 more elements
(canceled)
Dependencies are inferred from the claim text.